Exploration of 3,4-unsubstituted coumarins as thioredoxin reductase 1 inhibitors for cancer therapy

The synthesis and estimation of the structure–activity relationship of a range of 3,4-unsubstituted coumarins are described. Natural-like scaffold of coumarin remains a privileged source of potential TrxR1 inhibitors for anticancer application.